Ligand Pharmaceuticals | Umlaufvermögen



Current Assets Veränderung Datum
Amgen USD 29.03B 2.26B 2024-12
Arrowhead Research USD 570.54M 124.93M 2024-12
Baxter International USD 8.85B 11M 2024-12
Bristol-Myers Squibb USD 29.78B 1.7B 2024-12
Eli Lilly USD 32.74B 1.32B 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 17B 301M 2024-12
Glaxosmithkline GBP 17B 301M 2024-12
Insmed USD 1.62B 28.18M 2024-12
Ionis Pharmaceuticals USD 2.62B 93.56M 2024-12
Ligand Pharmaceuticals USD 331.56M 22.17M 2024-12
MacroGenics USD 217.49M 4.71M 2024-12
Merck USD 38.78B 1.58B 2024-12
Pacira USD 745.13M 55.16M 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Veracyte USD 372.27M 15.41M 2024-12



Ligand Pharmaceuticals Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.